Induction of humoral and cell-mediated immunity to hepatitis B surface antigen by a novel adjuvant activity of Oka varicella vaccine

References

1. Abbas A. K., Murphy K. M., Sher A. 1996; Functional diversity of helper T lymphocytes. Nature 383:787–793
   [Google Scholar]
2. Arvin A. M., Gershon A. A. 1996; Live attenuated varicella vaccine. Annu Rev Microbiol 50:59–100
   [Google Scholar]
3. Asano Y., Shiraki K., Takahashi M., Nagai H., Ozaki T., Yazaki T. 1981; Soluble skin test antigen of varicella-zoster virus prepared from the fluid of infected cultures. J Infect Dis 143:684–692
   [Google Scholar]
4. Asano Y., Itakura N., Hiroishi Y. 7 other authors 1985; Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients. J Infect Dis 152:863–868
   [Google Scholar]
5. Baba K., Tsuda N., Yabuuchi H., Konishi S., Fujinami A., Tsujino G., Takahashi M. 1980; Prevention of varicella in urgent cases by passive transfer of vaccine-induced immunity. Biken J 23:89–94
   [Google Scholar]
6. Berger R., Luescher D., Just M. 1984; Enhancement of varicella-zoster-specific immune responses in the elderly by boosting with varicella vaccine. J Infect Dis 149:647–649
   [Google Scholar]
7. Berger R., Trannoy E., Hollander G., Bailleux F., Rudin C., Creusvaux H. 1998; A dose-response study of a live attenuated varicella-zoster virus (Oka strain) vaccine administered to adults 55 years of age and older. J Infect Dis 178 (Suppl. 1):S99–S103
   [Google Scholar]
8. Diaz P. S., Smith S., Hunter E., Arvin A. M. 1989; T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine. J Infect Dis 142:636–641
   [Google Scholar]
9. Finkelman F. D. 1995; Relationships among antigen presentation, cytokines, immune deviation, and autoimmune disease. J Exp Med 182:279–282
   [Google Scholar]
10. Heineman T. C., Connelly B. L., Bourne N., Stanberry L. R., Cohen J. 1995; Immunization with recombinant varicella-zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs. J Virol 69:8109–8113
    [Google Scholar]
11. Jack A. D., Hall A. J., Maine N., Mendy M., Whittle H. C. 1999; What level of hepatitis B antibody is protective?. J Infect Dis 179:489–492
    [Google Scholar]
12. Jenkins D. E., Redman R. L., Lam E. M., Liu C., Lin I., Arvin A. M. 1998; Interleukin (IL)-10, IL-12, and interferon-γ production in primary and memory immune responses to varicella-zoster virus. J Infect Dis 178:940–948
    [Google Scholar]
13. Kamiya H., Ihara T., Hattori A., Iwasa T., Sakurai M., Izawa T., Yamada A., Takahashi M. 1977; Diagnostic skin reactions with varicella virus antigen and clinical application of the test. J Infect Dis 136:784–788
    [Google Scholar]
14. Kamiyama T., Sato H., Takahara T., Kageyama S., Shiraki K. 2000; Novel immunogenicity of Oka varicella vaccine vector expressing hepatitis B surface antigen. J Infect Dis 181:1158–1161
    [Google Scholar]
15. LaRussa P., Steinberg S. P., Seeman M. D., Gershon A. A. 1985; Determination of immunity to varicella-zoster virus by means of an intradermal skin test. J Infect Dis 152:869–875
    [Google Scholar]
16. Lau D. T., Khokhar M. F., Doo E. 10 other authors 2000; Long-term therapy of chronic hepatitis B with lamivudine. Hepatology 32:828–834
    [Google Scholar]
17. Levin M. J., Murray M., Zerbe G. O., White C. J., Hayward A. R. 1994; Immune response of elderly persons 4 years after receiving a live attenuated varicella vaccine. J Infect Dis 170:522–526
    [Google Scholar]
18. Levin M. J., Barber D., Goldblatt E., Jones M., LaFleur B., Chan C., Stinson D., Zerbe G. O., Hayward A. R. 1998; Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect. J Infect Dis 178 (Suppl. 1):S109–S112
    [Google Scholar]
19. Moser M., Murphy K. M. 2000; Dendritic cell regulation of Th1–Th2 development. Nat Immunol 1:199–205
    [Google Scholar]
20. Rossol S., Marinos G., Carucci P., Singer M. V., Williams R., Naoumov N. V. 1997; Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest 99:3025–3033
    [Google Scholar]
21. Sato H., Kageyama S., Imakita M., Ida M., Yamamura J., Kurokawa M., Shiraki K. 1998; Immune response to varicella-zoster virus glycoproteins in guinea pigs infected with Oka varicella vaccine. Vaccine 16:1263–1269
    [Google Scholar]
22. Shiraki K., Yamanishi K., Takahashi M. 1984; Biologic and immunologic characterization of the soluble skin-test antigen of varicella-zoster virus. J Infect Dis 149:501–504
    [Google Scholar]
23. Shiraki K., Hayakawa Y., Mori H., Namazue J., Takamizawa A., Yoshida I., Yamanishi K., Takahashi M. 1991; Development of immunogenic recombinant Oka varicella vaccine expressing hepatitis B virus surface antigen. J Gen Virol 72:1393–1399
    [Google Scholar]
24. Shiraki K., Sato H., Yamamura J., Li Z. H., Yokoyama T., Hasegawa T., Okuno T., Kurokawa M., Kageyama S. 1997; Functions of purified gB, gE : gI, and gH : gL, and their sialyl residues in varicella-zoster virus infection. Arch Virol 142:2295–2301
    [Google Scholar]
25. Shiraki K., Sato H., Yoshida Y., Yamamura J., Tsurita M., Kurokawa M., Kageyama S. 2001; Construction of Oka varicella vaccine expressing human immunodeficiency virus Env antigen. J Med Virol 64:89–95
    [Google Scholar]
26. Singh M., O'Hagan D. 1999; Advance in vaccine adjuvants. Nat Biotechnol 17:1075–1081
    [Google Scholar]
27. Takahashi M., Otsuka T., Okuno Y., Asano Y., Yazaki T. 1974; Live vaccine used to prevent the spread of varicella in children in hospital. Lancet ii:1288–1290
    [Google Scholar]
28. Takahashi M., Iketani T., Sasada K., Hara J., Kamiya H., Asano Y., Baba K., Shiraki K. 1998; Immunization of the elderly and patients with collagen vascular diseases with live varicella vaccine and use of varicella skin antigen. J Infect Dis 166 (Suppl. 1):S58–S62
    [Google Scholar]
29. Takahashi M., Kamiya H., Asano Y., Shiraki K., Baba K., Otsuka T., Hirota T., Yamanishi K. 2001; Immunization of the elderly to boost immunity against varicella-zoster virus (VZV) as assessed by VZV skin test reaction. Arch Virol 17:161–172
    [Google Scholar]
30. Vazquez M., LaRussa P. S., Gershon A. A., Steinberg S. P., Freudigman K., Shapiro E. D. 2001; The effectiveness of the varicella vaccine in clinical practice. New Engl J Med 344:955–960
    [Google Scholar]